All Eyes on ExPEC: A Major Driver of Invasive Disease and Antimicrobial Resistance

Here’s my summary of our current knowledge about extraintestinal pathogenic Escherichia coli and the challenges and opportunities associated with vaccine development for these bacteria.

Julie Ann Justo, PharmD, MS Released: August 31, 2022

Preventive measures such as vaccination are strong antimicrobial stewardship tools that need more development so the attention is not focused only on the development of new antibiotics. Here are my thoughts on the current landscape of vaccines against extraintestinal pathogenic Escherichia coli.

Lilian Abbo, MD, FIDSA Released: October 6, 2022

Extraintestinal pathogenic E coli (ExPEC) has been around for a long time and will likely remain clinically important in the foreseeable future. Read Dr David van Duin’s thoughts on why this is a concern and what populations are at highest risk for developing ExPEC invasive infections.

David Van Duin, MD, PhD, FIDSA, FAST Released: December 6, 2022